SANGAMO THERAPEUTICS, INC - 8-K Filing
Sangamo Therapeutics entered into an asset purchase agreement with PTC for $111M upfront and up to $100M in contingent milestone payments. (Items: 1.01 Entry into a Material Definitive Agreement, 1.03 of this Current Report on Form 8-K under the heading “PTC Asset Purchase Agreement” is incorporated herein by reference, 9.01 Financial Statements and Exhibits)
Tickers: $SGMO